CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

How Data Science is Revolutionizing Genomics

How Data Science is Revolutionizing...

Human-specific Proteins Uncovered by Exploring Genetic Uncharted Territory

Human-specific Proteins Uncovered by...

A Broader Perspective of Genomics

A Broader Perspective of Genomics

The Future Of Genomics In Theory-Focused Approaches

The Future Of Genomics In...

Role of Human Genomic Data in Future

Role of Human Genomic Data in Future

Essentiality of Single-cell Genomics Technology

Essentiality of Single-cell Genomics...

Tactics to Handle Genomic Data

Tactics to Handle Genomic Data

Benefits of Advanced Genomic Testing

Benefits of Advanced Genomic Testing

How Data Science is Revolutionizing Genomics

How Data Science is Revolutionizing...

Human-specific Proteins Uncovered by Exploring Genetic Uncharted Territory

Human-specific Proteins Uncovered by...

A Broader Perspective of Genomics

A Broader Perspective of Genomics

The Future Of Genomics In Theory-Focused Approaches

The Future Of Genomics In...

Role of Human Genomic Data in Future

Role of Human Genomic Data in Future

Essentiality of Single-cell Genomics Technology

Essentiality of Single-cell Genomics...

Tactics to Handle Genomic Data

Tactics to Handle Genomic Data

Benefits of Advanced Genomic Testing

Benefits of Advanced Genomic Testing

Daniel Spatz Joins CellGenix as Vice President Sales, Marketing & Logistics and Member of the Management Team

Life Sciences Review | Thursday, August 26, 2021
Tweet

CellGenix announces the appointment of Daniel Spatz as Vice President of Sales, Marketing & Logistics and a member of the management team.


FREMONT, CA: CellGenix, a worldwide manufacturing leader in GMP-grade raw materials for cell therapy, gene therapy, and tissue-engineered items, is happy to announce the addition of Daniel Spatz as Vice President of Sales, Marketing & Logistics and a member of the management team.


Daniel became the Head of Marketing & Sales and Logistics at CellGenix in 2021. In their headquarters in Germany, he controls the overall global sales and marketing department, along with logistics transport and customer support. He will now serve these critical areas in the management team and help to improve their global position as a premium raw material supplier. Prof. Dr. Felicia M. Rosenthal (Chief Executive Officer), Dr. Bernd Leistler (Vice President Production), Dr. Udo Nirenberg (Vice President Quality Control), and Dr. Till Puschmann (Vice President R&D and Business Development) completes the management team.


“We are delighted to welcome Daniel Spatz in our management team,” said Prof. Felicia Rosenthal, CEO of CellGenix. “Daniel has extensive global marketing and sales experience in the life science field and a proven track record. I am confident that he will prove to be an important addition to our management team as CellGenix continues to expand and build on its leading position as premium supplier of high-quality raw materials for cell and gene therapy manufacturing. We welcome him in our management team and look forward to continuing working with him.”


“I am very excited to join the management team of CellGenix and help build on the solid foundation developed over the last 25+ years,” said Daniel Spatz. “With comprehensive knowledge and hands-on experience of developing a cell therapy ourselves, CellGenix is an expert in GMP manufacturing of raw materials for cell and gene therapies. I am looking forward to sharing my vast experience and know-how to continue to drive CellGenix growth in the cell and gene therapy market and ensure continuous and optimal customer support.”


Weekly Brief

loading
Top 10 Genomics Solutions Companies in Europe/UK – 2022
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/daniel-spatz-joins-cellgenix-as-vice-president-sales-marketing-logistics-and-member-of-the-management-team-nwid-343.html